Therapy News and Research

RSS

Altherx Pharmaceuticals receives U.S. patent for use of solabegron for treatment of overactive bladder

AltheRx Pharmaceuticals, a privately-held clinical development company, today announced the United States Patent and Trademark Office issued a Notice of Allowance for the company's U.S. Patent Application claiming a method of use for solabegron, a beta 3-adrenergic receptor agonist, in combination with all commercially available antimuscarinics at both therapeutic and sub-therapeutic doses for the treatment of overactive bladder (OAB).

18 Oct 2013

GenSpera to present G-202 Phase I trial in hepatocellular carcinoma at EORTC-NCI-AACR Symposium

GenSpera, Inc. (OTCBB:GNSZ) announced that Devalingam Mahalingam, MD, PhD, principal investigator of the G-202 Phase II trial in hepatocellular carcinoma, will present data from the G-202 Phase I clinical trial at the EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics in Boston, MA on Monday, October 21st.

18 Oct 2013

Two drugs in combination improve survival in patients with advanced pancreatic cancer

Investigators at the Vall d´Hebron University Hospital and the Vall d'Hebron Institute of Oncology (VHIO), have participated in an international phase III study, published in The New England Journal of Medicine.

18 Oct 2013

Use of effective, risky drug therapies by Medicare patients varies across US

A new report from the Dartmouth Atlas Project shows that the use of both effective and risky drug therapies by Medicare patients varies widely across U.S. regions, offering further evidence that location is a key determinant in the quality and cost of the medical care that patients receive.

18 Oct 2013

Atorvastatin drug plus zoledronic acid may help treat toxoplasmosis

Researchers at the University of Georgia have discovered that a combination of two commonly prescribed drugs used to treat high cholesterol and osteoporosis may serve as the foundation of a new treatment for toxoplasmosis, a parasitic infection caused by the protozoan Toxoplasma gondii. They published their findings recently in PLOS Pathogens.

18 Oct 2013

Inducing asthma control key to long-term outcomes

Patients with uncontrolled asthma should receive intensive management and follow-up, say researchers who found that good asthma control at one point in time is associated with increased likelihood for control over the subsequent year.

17 Oct 2013

Stem Cell Therapeutics Nabs Sirpa Protein-Targeting Mabs

...

17 Oct 2013

Astrazeneca, Taiwan's NRPB Launch Drug Discovery Collaboration

...

17 Oct 2013

Discovery Labs submits IND application to start AEROSURF phase 2 clinical program

Discovery Laboratories, Inc., a specialty biotechnology company dedicated to advancing a new standard of respiratory critical care, today announced that it has submitted an investigational new drug application to the U.S. Food and Drug Administration to initiate its AEROSURF phase 2 clinical program.

17 Oct 2013

AmpliPhi, University of Leicester partner to develop novel bacteriophage therapy against C. difficile

AmpliPhi BioSciences Corporation, the leader in the development of bacteriophage-based antibacterial therapies to treat antibiotic resistant infections, announces it has entered into Collaboration and License Agreements with UK-based University of Leicester to develop a novel bacteriophage therapy targeting Clostridium difficile, a serious gastrointestinal infection for which new treatments are urgently required.

17 Oct 2013

Review article looks at recent research about insomnia among American soldiers

Various behavioral treatment options are helping to treat the sleeplessness experienced by one in every two American soldiers who have been deployed in recent military operations. So says Dr. Adam Bramoweth of the Department of Veterans Affairs Pittsburgh Healthcare System, and Dr. Anne Germain of the University of Pittsburgh School of Medicine in the US.

17 Oct 2013

Good news: Knowing risk early, women can take action to prevent osteoporosis

On World Osteoporosis Day, October 20, the International Osteoporosis Foundation (IOF) is calling for women to take action now to protect their bone health. Broken bones due to osteoporosis often result in pain, immobility and loss of quality of life as well as early death.

17 Oct 2013

Overutilization of radioactive iodine to treat PTC leads to worse access to health care

The American Thyroid Association (ATA) recommends against the routine use of radioactive iodine after surgery to remove the thyroid in patients with low-risk papillary thyroid cancer (PTC).

17 Oct 2013

CardioFocus completes HeartLight EAS pivotal trial enrollment for symptomatic paroxysmal AF

CardioFocus, Inc., developer of the HeartLight Endoscopic Ablation System for the treatment of atrial fibrillation, today announced that it has concluded enrollment of its U.S. pivotal trial evaluating the HeartLight system, for the treatment of symptomatic paroxysmal AF.

17 Oct 2013

Study shows that brains process pain of villains more than pain of people we like

Counterintuitive findings from a new USC study show that the part of the brain that is associated with empathizing with the pain of others is activated more strongly by watching the suffering of hateful people as opposed to likable people.

17 Oct 2013

Respicardia awarded U.S. Healthcare Product of the Year for remede System

Respicardia®, Inc., a developer of implantable therapies to improve respiratory and cardiovascular health, announced that it has been awarded the U.S. Healthcare Product of the Year by Acquisition International for the remede System, the first and only implantable device for the treatment of central sleep apnea.

16 Oct 2013

Proper sleep helps maintain a healthy lifestyle

Three new studies show just how critical it is for adults to seek treatment for a sleep illness and aim for seven to nine hours of sleep each night in order to maintain a healthy lifestyle.

16 Oct 2013

Detroit Lions, Josephine Ford Cancer Institute to raise $15M for cancer research in metro Detroit

The Detroit Lions and Josephine Ford Cancer Institute, Michigan's largest provider of adult cancer care, have created a unique partnership with the goal to raise $15 million during the next three years for cancer research in metro Detroit.

16 Oct 2013

Trovagene launches pharmaceutical alliance to monitor lung cancer patients' EGFR mutational status

Trovagene, Inc., a developer of cell-free molecular diagnostics, today announced that it will collaborate with a pharmaceutical company to evaluate Trovagene's proprietary, urine-based, cell-free DNA technology for the detection of certain epidermal growth factor receptor mutations associated with lung cancer.

16 Oct 2013

Get With The Guidelines--Stroke hospitals provide recommended guideline-based care for patients

Award-winning Get With The Guidelines--Stroke hospitals are more likely than Primary Stroke Center certified hospitals to provide all the recommended guideline-based care for patients, according to new research in the Journal of the American Heart Association.

16 Oct 2013

Therapy News and Research

Altherx Pharmaceuticals receives U.S. patent for use of solabegron for treatment of overactive bladder

GenSpera to present G-202 Phase I trial in hepatocellular carcinoma at EORTC-NCI-AACR Symposium

Two drugs in combination improve survival in patients with advanced pancreatic cancer

Use of effective, risky drug therapies by Medicare patients varies across US

Atorvastatin drug plus zoledronic acid may help treat toxoplasmosis

Inducing asthma control key to long-term outcomes

Stem Cell Therapeutics Nabs Sirpa Protein-Targeting Mabs

Astrazeneca, Taiwan's NRPB Launch Drug Discovery Collaboration

Discovery Labs submits IND application to start AEROSURF phase 2 clinical program

AmpliPhi, University of Leicester partner to develop novel bacteriophage therapy against C. difficile

Review article looks at recent research about insomnia among American soldiers

Good news: Knowing risk early, women can take action to prevent osteoporosis

Overutilization of radioactive iodine to treat PTC leads to worse access to health care

CardioFocus completes HeartLight EAS pivotal trial enrollment for symptomatic paroxysmal AF

Study shows that brains process pain of villains more than pain of people we like

Respicardia awarded U.S. Healthcare Product of the Year for remede System

Proper sleep helps maintain a healthy lifestyle

Detroit Lions, Josephine Ford Cancer Institute to raise $15M for cancer research in metro Detroit

Trovagene launches pharmaceutical alliance to monitor lung cancer patients' EGFR mutational status

Get With The Guidelines--Stroke hospitals provide recommended guideline-based care for patients

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

Latest News